Regulation of regenerative medicine in the UK 1. We all want to see research continue to thrive in the UK. To ensure this, as regulators we must facilitate high quality research, manufacture and clinical use. Effective r

First Page		Document Content
Date: 2013-06-28 11:06:55 Cloning Developmental biology Stem cells Medicines and Healthcare products Regulatory Agency Human Fertilisation and Embryology Authority Regenerative medicine Embryonic stem cell Human Tissue Authority Biology Department of Health Biotechnology		Regulation of regenerative medicine in the UK 1. We all want to see research continue to thrive in the UK. To ensure this, as regulators we must facilitate high quality research, manufacture and clinical use. Effective r Add to Reading List Source URL: www.hta.gov.uk Download Document from Source Website File Size: 189,21 KB Share Document on Facebook

	China Regenerative Medicine International Limited 中國再生醫學國際有限公司 Incorporated in the Cayman Islands with limited liability 於開曼群島註冊成立之有限公司 Stock Code 股份代號：8158 DocID: 1vnZo - View Document
	[For immediate release] [Press Release] China Regenerative Medicine International Limited (Stock Code: 8158.HK) DocID: 1vlMf - View Document
	Centre for Cell Therapy and Regenerative Medicine 6th Margaret River Region Forum and 9th ASSCR Annual Scientific Meeting Stem Cells: Fundamental Biology and Clinical Translation DocID: 1v4Rh - View Document
	May 24, 2018 CollPlant Reports First Quarter 2018 Financial Results and Provides Business Update NESS ZIONA, Israel, May 24, 2018 /PRNewswire/ -CollPlant (NASDAQ: CLGN) (TASE: CLGN), a regenerative medicine company util DocID: 1uYu4 - View Document
	China Regenerative Medicine International Limited 中國再生醫學國際有限公司 Annual Report 年報 DocID: 1uNPZ - View Document